Juan Rios Fuentes, MD
Orthopaedic Surgery · Manati, PRNPI 1922014109
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (30.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Smith+Nephew at 53.9% of the total. Reporting peaked in 2019 at $3,262 and has fallen 66.8% since, to $1,082 in 2025.
Across 48 payments — averaging $194.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$5K
- Arthrex$1K
- RMC Orthopedic & Surgical, Inc.$1K
- Microport Orthopedics Inc$568
- Stryker$377
- Encore Medical, LP$276
- plus $192 from 4 others
What the payments were for
- Speaking & faculty fees$2,46026%
- Travel & lodging$2,80630%
- Food & beverage$2,07622%
- Education$2,00021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 20 | $5,032 |
| Arthrex | 3 | $1,458 |
| RMC Orthopedic & Surgical, Inc. | 4 | $1,439 |
| Microport Orthopedics Inc | 4 | $568 |
| Stryker | 7 | $377 |
| Encore Medical, LP | 5 | $276 |
| Johnson & Johnson | 2 | $85 |
| Johnson And Johnson International | 1 | $70 |
| Chiesi USA, Inc. | 1 | $19 |
| PBG Puerto Rico LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,343 in reported general payments places this provider in the 80th percentile of 94 orthopaedic surgery providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Potassium | 1,143 | $32,560 |
| Diclofenac Sodium ErDiclofenac Sodium | 60 | $2,849 |
| Cefadroxil | 160 | $1,741 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 98 | $1,384 |
| Nabumetone | 91 | $1,266 |
| Enoxaparin Sodium | 164 | $981 |
| Methylprednisolone | 96 | $943 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 69 | $734 |
| Celecoxib | 32 | $433 |
| Meloxicam | 66 | $334 |
| Sulindac | 12 | $173 |
| Gabapentin | 31 | $143 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Manati
- Hector Sanchez FernandezManati$4K
- Jaime FumeroManati$2K
- Carlos Carrion LorenzoManati$923
- Alberto Rivera RosadoSanturce$197K
- Andres Muniz MartinezCayey$56K
- David Beaton ComuladaSan Juan$29K
- John KaganHumacao$27K
- Juan Santiago TorresHatillo$24K
- Ariel Davila-ParrillaSan Juan$21K
- Francisco Lopez-GonzalezSan Juan$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.